|Articles|July 14, 2015
New Release Clinical Conductor CTMS
The new Clinical Conductor contains a myriad of enhancements that foster more precise reporting and analysis.
Advertisement
Bio-Optronics announces its Clinical Conductor CTMS has been updated with enhancements that include:
- Adverse Event (AE/SAE) management enhancements (e.g. wizards for reporting, audit trails for review, document uploads, etc.)
- Billing compliance review functionality additions at the site level, as well as the enterprise level for sponsors, CROs, health systems and other networks
- Invoicing features that allow organizations to set invoicing caps, frequencies and much more.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- How the NIMBLE Study Supported Adherence With Quarterly Dosing of Cemdisiran
September 18th 2025
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Why Clinical Trials Are at a Crossroads and How Site Networks Are the Key to Success
2
IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
3
Everything to Know About FDA’s Push Towards Radical Transparency in 2025
4
Enhancing Clinical Trial Data Accuracy Through the IQVIA and Veeva Partnership
5